Skip to main content
International Journal of Reproductive Biomedicine logoLink to International Journal of Reproductive Biomedicine
. 2020 Sep 20;18(9):747–754. doi: 10.18502/ijrm.v13i9.7669

Role of the 820 A/G variant in the IGF-2 gene and recurrent spontaneous abortion in southern Iran: A cross-sectional study

Farzaneh Ardeshir 1, Leila Keshavarz 1, Fatemeh Asadian 2, Gohar Omidmokhtarkhanloo 1, Majid Yavarian 3,4
PMCID: PMC7521167  PMID: 33062920

Abstract

Background

Insulin-like growth factor-2 (IGF-2) is a polypeptide growth factor and one of the first genes expressed prior to the implantation of the embryo, with its highest expression in the placental cells. Its activity strongly depends on the genomic imprinting, and the result of the loss of genetic imprinting is the termination of the early stages of embryonic development, which can lead to recurrent spontaneous abortion.

Objective

This cross-sectional study aimed to investigate the role of 820A/G variant of the IGF-2 gene and the probability to recurrent spontaneous abortion (RSA) in southern Iran.

Materials and Methods

In this study, 50 aborted fetuses tissue for the study group and blood samples umbilical-cord from newborns as control group (n = 50) were collected from Shiraz-Iran (2017). The genotyping of the target point in the IGF-2 gene was performed by Real-time Polymerase Chain Reaction and analyzed through high-resolution melting (HRM) curve.

Results

Based on the collected data (AA genotype = reference), allele “A” frequency in aborted fetus was 51% and control 68% as well as allele G 49% and 32%, respectively. Moreover, 27 aborted embryos (54%) were heterozygous (A/G) (OR = 3.274, 95% CI = 1.015-10.561, p = 0.04), while 18 cases (36%) in control sample showed heterozygosity. Considering the phenotypic status, the G allele had a dominant effect on the incidence of RSA (p = 0.008, OR = 3.167).

Conclusion

Based on the present study, the risk of abortion due to loss of heterozygosity or quantitative decline of the IGF-2 is about three-fold in the southern Iran.

Keywords: Variant, IGF-2, Spontaneous abortion, Genomic imprinting, Gene expression

1. Introduction

Recurrent spontaneous abortion (RSA) is referred to three or more times of spontaneous fetal death prior to the 20th wk of pregnancy (1, 2). Several genetic and non-genetic factors may induce RSA, such as polycystic ovarian syndrome and quantitative and structural chromosomal abnormalities. It is generally accepted that the most common factors in the first trimester abortion is caused by chromosomal abnormalities (3, 4). It is believed that etiological causes of RSA usually are unclear in 30-50% of cases (5). As a result, some idiopathic abortions may be caused by genetic variant that changes in specific genes. These variations, so-called imprinted genes, could affect maternal or paternal genome activity and lead to RSA (6). Genomic imprinting is an epigenetic modification that affects gene expression in paternally or maternally originated genes. This process contradicts Mendelian inheritance. These genes do not have biallelic expression and only one allele is expressed in the genomic imprinting process, depending on the allelic origin of the parents (7).

In human, around 60 genes identified that is affected by the phenomenon of genetic imprinting (8, 9). Their expressions are critical during developmental fetal times. Many of them are regulatory genes involved in the growth and development of the fetus and are functionally hemizygous pattern. Therefore, alteration of effective copy number can cause developmental disorders.

Among these genes, the Insulin-like growth factor-2 (IGF-2) gene at the position 11p15.5 is paternally expressed in fetus (10). The position in chromosome includes an imprinting region that contains the IGF2 gene, which is consequently linked to the H19 gene. The IGF2/H19 expression is regulated by two imprinting control regions (ICR1 and ICR2). The ICR1 is a differentially methylated region at the upstream H19 promoter (11, 12). On the maternal allele, the CTCF protein, a zinc finger protein, binds to differentially methylated region (13, 14) and subsequently un-methylated maternal allele prevents IGF-2 interaction with an H19 enhancer at the downstream and inhibits IGF-2 expression. Methylation of this region on a paternal allele changes the expression of gene profile and favors IGF-2 expression (15). IGF-2 gene-encoded protein is involved in prenatal growth and is highly active during embryonic development. The activity of the IGF-2 gene depends on the copy that is inherited from the father (16). IGF-2 gene regulates the growth rate of the placenta and the embryo through angiogenesis (17-20), nutrient transfer (21), and inhibition of apoptosis (22), and its dysfunction can lead to miscarriage (23, 24). The IGF-2 gene has single nucleotide polymorphism in its different regions that affects its expression quantities and function. One of such known single nucleotide polymorphism is 820A/G variant (25). This variant in the father reduces gene expression and leads to abortion (26). The diagnosis of paternal 820 A/G-genotypes of the IGF-2 gene helps to predict the prospect of fetal loss due to gene imprinting.

This study was intended to inspect the frequency and potential effects of alleles in women with recurrent abortions to open a way to prevent this public burden.

2. Materials and Methods

Samples

During a period of six months (May-October 2017), for a cross-sectional study, 232 dead fetuses were collected from the labor wards of Hafez and Zeinabiea Hospitals, Shiraz-Iran. Ninety one of collected fetuses were from mothers who had experienced at least two or more consecutive miscarriages. Additionally, 22 cases were excluded due to abnormal sonography or maternal abnormal lab data. All fetuses with abnormal karyotype or Noninvasive prenatal testing (NIPT) (19 cases) were excluded from the study as well. Finally, 50 fetal tissue samples with normal karyotype were enrolled and included for molecular analysis. A match group was randomly selected from 50 mothers who had at least one delivery after 37 wk gestation as the control group and blood samples were taken from the neonates. Cases with non-spontaneous abortions as well as known disorders or anatomical abnormalities were excluded from the study. Demographic data of dead fetuses and controls presented in table I.

About 1 cm of aborted fetal tissue was stored at -20°C and used for DNA extraction. Samples were collected through questionnaire requiring information with spouse at the time of admission.

Genetic analysis

Genomic DNA was extracted using PureLink genomic DNA kit (Life Technologies, CA, USA) according to the manufacturer's instruction. Quality and quantity of DNA were investigated using 0.8% agarose gel (Sigma-Aldrich, USA) electrophoresis and Nanodrop spectrophotometer device (BioTek Company,Germany). For the 820 A/G genotyping, Real-time Polymerase Chain Reaction was done with LC-Green (Idaho Technology, Salt Lake City, Utah, USA), and a high-resolution melting (HRM) analysis method following PCR amplification (Qiagen company, USA) was performed.

All samples were run along with positive and normal controls that were originally approved by Sanger sequencing method. Data were analyzed and genotyped using the HRM software.

Real-time PCR reactions and melting analysis

A 10 µL reaction mixture with the Master Mix (2×) (Promega, Madison, WI, USA), LC Green Plus (10×) (Idaho Technology, Salt Lake City, Utah, USA) prepared. Final concentration of primers mixture and DNA was 10 µM and 200 pg/µL, respectively. The sequence of primers for IGF-2 (820A/G) design was done by online Primer 3 software. The sequence of designed primers are: (5'-CTT GAG TCC CTG AAC CAG CA-3') and (5'-TTC GGA TGG CCA GTT TAC CC-3'). The reaction PCR conditions were: initial cycle 95°C for 90 sec, followed by 30 cycles of 95°C for 25 sec, and annealing and extension temperature for 30 sec with final extension of 72°C for 2 min. Melting analysis at the range of 65-95°C with an increment 0.1°C for 10 s was performed. Bio-Rad Precision Melt Analysis Software, version 1.2 (Bio-Rad Laboratories Inc., USA) was used for data analysis (Figure 1).

Table 1.

Demographic data of cases and controls


Characteristic Aborted fetus (n = 50) Control group (n = 50) P-value*
Range of mother age (yr) 26-39 25-38
Average of mother age (yr)* 32.77 ± 4.23 32.59 ± 3.89 0.942
Average of fetus age* 12.05 ± 3.2    -
Average age of infants born*    - 38.54 ± 1.16
Range number of abortions 3-4    -
Average number of abortions* 3.05 ± 1.64    -
Data presented as Mean ± SD. *P-value by Student t test

Figure 1.

Figure 1

HRM analysis results to determine the genotype of the positional products polymorphisms 820 G/A in the IGF-2 gene. The Real-time device shows diagram based on fluorescence variations relative to temperature variations. In this chart, each of the peaks represents the melting of a product PCR and, accordingly, determines the genotype.

Ethical consideration

The research was performed with the approval Ethics Committee of Islamic Azad University of Dehaghan Branch, Dehaghan, Iran (Code: IR.IAU.DEHAGHAN.REC.1397.001). Written informed consent was obtained from all candidates before taking samples.

Statistical analysis

The statistical analysis was performed using the SPSS software (Statistical Package for the Social Sciences, version 22; SPSS, Chicago, IL, USA) and Chi-square (χ2) test by analysis of logistic regression; p < 0.05 was considered as the level of significance and A/G distribution was in agreement with the Hardy-Weinberg equilibrium (HWE). Odds ratio (OR) and p-value with 95% confidence interval (CI) were considered to estimate the risk RSA for 820A/G variant in the IGF-2 gene in the study group with RSA and control groups. Student's t test was used to compare the mean age of the mothers between the two groups and Fisher's exact test for p- value.

3. Results

In present study, there was no significant difference between the mean age of mothers, the mothers of the control group with age 32.59 ± 3.89 yr compared to the mothers of aborted fetuses with age 32.77 ± 4.23 (p = 0.942) (Table I). The allelic and genotypic frequency of 820 A/G in the IGF-2 gene was studied in case and control groups. The ancestral allele A is considered as the reference. Based on the results of the statistical analysis revealed, the G allele is effective in recurrent abortions (p = 0.015). Considering the AA-genotype, as reference and analysis of other genotypes relative to this position obtained a statistically significant relationship (p = 0.04 for AG- genotype and p = 0.935 for GG-genotype). The AG genotype is effective in the incidence of recurrent miscarriage; the calculated OR showed that A/G genotype of the IGF-2 gene at 820 locus increased the incidence of spontaneous abortion more than three-fold. Considering the phenotypic status to the advantage of allele dominance in G, a significant relationship was obtained. The statistical analysis results are presented in Table II.

Table 2.

The distribution of genotypes and alleles of 820A/G in the IGF-2 gene in control and aborted fetus s with RSA


Genotype/Allele Control group Aborted fetus Odds ratio CI%95 P-value*
AA 25 (50) 12 (24) _ Reference -
AG 18 (36) 27 (54) 3.274 1.015-10.561 0.04
GG 7 (14) 11 (22) 1.048 0.342-3.210 0.935
A 68 (68) 51 (51)    - Reference -
G 32 (32) 49 (49) 2.042 3.627-1.149 0.015
GG+AG (G+) 25 (50) 38 (76) 3.167 1.349-7.435 0.008
AA+AG (A+) 43 (86) 39 (78) 0.577 0.204-1.636 0.301
Data presented as n (%).*P-value by Fisher's exact test

4. Discussion

The cause and mechanism underlying the traits and conditions that induce recurrent abortion is an important challenge for current genetics. Now, it is well-accepted that some human traits depend on the parent from whom the gene responsible for the trait is inherited. Obviously, the zygotes that were generated by maternally or paternally derived chromosomes could not survive to term. Development failure results from the entire chromosome complement inherited from only one parent. Comparison of gross morphologic complementarity of the phenotypes resulting from paternal sets of chromosomes versus maternal sets suggests that paternal genetic contribution is important for placental development, while maternal contribution is essential for proper embryo development (27).

Recently, frequent reports indications a connection between pregnancy complications such as restricted embryonic growth and RSA and the role of the IGF-2 gene. IGF-2 is known as a strong mitogen and is part of a cluster of imprinting genes on human chromosomes. Most imprinting genes are associated with embryo growth. The 820 A/G variation is a functional polymorphism and alter the primary sequence of encoded protein. This variation at the genomic level strongly affects the transcription level and alter IGF-2 expression status. Thus, mRNA transcription of the IGF-2 gene in the presence of this polymorphism will change quantatively. The G allele of the IGF-2 gene and plasma levels of IGF-2 protein as well as IGF-2 mRNA shows positive correlation. Therefore, heterozygote A/G at position 820 of this gene could results in loss of genomic imprinting manner in IGF-2 expression (25, 26, 28, 29).

The expression of the paternal allele is due to the changes in the epigenetic, including changes in the DNA structure such as DNA methylation. Imprinting genes or gene expression regulation is conducted via chromatin fiber change. The loss of the genetic imprinting (LOI) can result in a loss of the allele and imbalance (loss of function or increase in it) in a rate of the gene product and possibly also lead to the phenotypic outcome (30). Thus, the LOI leads to the loss of normal growth and development of the fetus. In order to clarify IGF-2 gene significance in the growth and development of pre-natal, Lighten and colleagues analyzed IGF genes and their receptors (IGF-1-IGF-2) expression in chorionic cells. Transcripts were evident that both genes and their receptors exist in human zygote cells before implantation. Although, according to the ligands, only transcripts of the IGF-2 ligand was detected. Based on their results, while before implantation, the parental allele function is blocked, genomic imprinting participated at the period of 8-cell embryo (31, 32). Therefore, it can be assumed that in RSA, the function of the genetic imprinting mechanism is not started, which results at the end of the growth of the organism (25).

Ostojic and co-worker have reviewed the genetic background of idiopathic RSA and the contribution of genetic changes to IGF-2 and H19 imprinting genes. This case-sectional study determined the relationship between IGF-2 820A/G and H19 HhaI gene variant RSA susceptibility. There was a significant difference in the frequency of IGF-2 820A/G in men with RSA compared to healthy men (p < 0.0001). There was no difference in the distribution of this genotypic women's groups. The presence of IGF-2 the 820 variant among the husbands of these women in RSA couples can affect the expression of IGF-2 in the placenta and embryo and represents a risk factor for RSA sensitivity (26). In addition, a study of 107 placental tissue samples from Ukraine reported that aborted embryos at 10-15 wk of pregnancy, carrier fetus with 820 A/G genotype, has seven times more chance to develop RSA as compared to the AA genotype (25). This study is also in line with the findings of Koukoura and colleagues from Greece who studied 31 placentas with fetal growth restriction (FGR) and found decline in IGF2 mRNA levels and LOI among the abnormal placentas. The epigenetic mechanism that regulates the genetic imprinting of the IGF-2 gene leads to FGR and induce significantly the reduction at the level of IGF-2 mRNA (15).

Although our study shows that the chance of RSA due to paternal G allele is increased about three times, this finding is still meaningfully lower than expected in comparison to the other study (Table III). The high rate of consanguinity marriage may introduce other possible genetic factors contributing to the development of RSA.

Table 3.

A Comparative view of this study (Fars-Iran) with Croatia and Ukraine


IGF-2 Genotype Control Patient OR P-value
A/G genotype
Iran 18 (36), n = 50 27 (54), n = 50 3.274 0.04
Croatia 28 (24.8), n = 113 54 (47.8), n = 113 3.274 < 0.0001
Ukraine 9 (0.225), n = 40 74 (0.692), n = 107 7.7239 < 0.01
G/G genotype
Iran 7 (14), n = 50 11 (22), n = 50 1.048 0.935
Croatia 22 (19.5), n = 113 44 (38.9), n = 113    - < 0.0001
Ukraine 27 (0.675), n = 40 22 (0.206), n = 107    - < 0.0001
Data presented as n (%); OR and P-value by Fisher's exact test

5. Conclusion

This study indicates that carriers of GG or A/G genotype are three times more likely to have recurrent abortion in our population.

Conflict of Interest

There is no conflict of interest in this study.

Acknowledgments

The authors are thankful to all their colleagues who collaborated in this study. This research was supported by Islamic Azad University, Arsanjan, Iran.

References

  • 1.Matthiesen L, Kalkunte S, Sharma S. Multiple pregnancy failures: an immunological paradigm. Am J Reprod Immunol 2012; 67: 334–340. [DOI] [PubMed]
  • 2.McNamee K, Dawood F, Farquharson R. Recurrent miscarriage and thrombophilia: An update. Curr Opin Obstet Gynecol 2012; 24: 229–234. [DOI] [PubMed]
  • 3.Roland L, Gagne A, Belanger MC, Boutet M, Julien P, Bilodeau JF. Plasma interleukin-18 (IL- 18) levels are correlated with antioxidant vitamin coenzyme Q (10) in preeclampsia. Acta Obstet Gynecol Scand 2010; 89: 360–366. [DOI] [PubMed]
  • 4.Huang HY. The cytokine network during embryo implantation. Chang Gung Med J 2006; 29: 25–36. [PubMed]
  • 5.Frequently asked questions: pregnancy. repeated miscarriages. The American College of Obstetricians and Gynecologists. Available at: URL: https://m.acog.org/Patients/FAQs/Repeated-Miscarriages.
  • 6.Cui H, Onyango P, Brandenburg S, Wu Y, Hsieh CL, Feinberg AP. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res 2002; 62: 6442–6446. [PubMed]
  • 7.Gurrieri F, Accadia M. Genetic imprinting: the paradigm of prader-willi and angelman syndromes. Endocr Dev 2009; 14: 20–28. [DOI] [PubMed]
  • 8.Moore GE, Oakey R. The role of imprinted genes in humans. Genome Biol 2011; 12: 106. [DOI] [PMC free article] [PubMed]
  • 9.Ulaner GA, Vu TH, Li T, Hu JF, Yao XM, Yang Y, et al. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site. Hum Mol Genet 2003; 12: 535–549. [DOI] [PubMed]
  • 10.Tycko B, Morison IM. Physiological functions of imprinted genes. J Cell Physiol 2002; 192: 245–258. [DOI] [PubMed]
  • 11.Horike SI, Ferreira JCP, Meguro-Horike M, Choufani S, Smith AC, Shuman C, et al. Screening of DNA methylation at the H19 promoter or the distal region of its ICR1 ensures efficient detection of chromosome 11p15 epimutations in Russell-Silver syndrome. Am J Med Genet A 2009; 149: 2415–2423. [DOI] [PubMed]
  • 12.Netchine I, Rossignol S, Dufourg MN, Azzi S, Rousseau A, Perin L, et al. 11p15 imprinting center region 1 loss of methylation is a common and specific cause of typical Russell-Silver syndrome: clinical scoring system and epigenetic-phenotypic correlations. J Clin Endocrinol Metab 2007; 92: 3148–3154. [DOI] [PubMed]
  • 13.Filippova GN, Fagerlie S, Klenova EM, Myers C, Dehner Y, Goodwin G, et al. An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes. Mol Cell Biol 1996; 16: 2802–2813. [DOI] [PMC free article] [PubMed]
  • 14.Rubio ED, Reiss DJ, Welcsh PL, Disteche CM, Filippova GN, Baliga NS, et al. CTCF physically links cohes in to chromatin. Proc Natl Acad Sci USA 2008; 105: 8309–8314. [DOI] [PMC free article] [PubMed]
  • 15.Koukoura O, Sifakis S, Soufla G, Zaravinos A, Apostolidou S, Jones A, et al. Loss of imprinting and aberrant methylation of IGF2 in placentas from pregnancies complicated with fetal growth restriction. Int J Mol Med 2011; 28: 481–487. [DOI] [PubMed]
  • 16.IGF2 gene. Genetics Home Reference. Available at: URL: https://ghr.nlm.nih.gov/gene/IGF2.
  • 17.McKinnon T, Chakraborty C, Gleeson LM, Chidiac P, Lala PK. Stimulation of human extra villous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein (s) and phosphorylation of MAPK. J Clin Endocrinol Metab 2001; 86: 3665–3674. [DOI] [PubMed]
  • 18.Lee OH, Bae SK, Bae MH, Lee YM, Moon EJ, Cha HJ, et al. Identification of angiogenic properties of insulin-like growth factor II in in vitro angiogenesis models. Br J Cancer 2000; 82: 385–391. [DOI] [PMC free article] [PubMed]
  • 19.Hills FA, Elder MG, Chard T, Sullivan MHF. Regulation of human villous trophoblast by insulin-like growth factors and insulin-like growth factor-binding protein-1. J Endocrinol 2004; 183: 487–496. [DOI] [PubMed]
  • 20.Herr F, Liang OD, Herrero J, Lang U, Preissner KT, Han VK, et al. Possible angiogenic roles of insulin-like growth factor II and its receptors in uterine vascular adaptation to pregnancy. J Clin Endocrinol Metab 2003; 88: 4811–4817. [DOI] [PubMed]
  • 21.Reik W, Constancia M, Fowden A, Anderson N, Dean W, Ferguson-Smith A, et al. Regulation of supply and demand for maternal nutrients in mammals by imprinted genes. J Physiol 2003; 547: 35–44. [DOI] [PMC free article] [PubMed]
  • 22.Stewart CE, Rotwein P. Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J Biol Chem 1996; 271: 11330–11338. [DOI] [PubMed]
  • 23.Soejima H, Yun K. Allele-specific-polymerase chain reaction: a novel method for investigation of the imprinted insulin-like growth factor II gene. Lab Invest 1998; 78: 641–642. [PubMed]
  • 24.Stray-Pedersen B, Stray-Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 1984; 148: 140–146. [DOI] [PubMed]
  • 25.Zastavna D, Makukh H, Tretjak B, Bilevych O, Tyrka M. Loss of Imprinting of IGF2 Gene in the Chorionic Tissues of Spontaneously 21-Eliminated Human Embryos. Genet Epigenet 2013; 5: 17–22. [DOI] [PMC free article] [PubMed]
  • 26.Ostojic S, Pereza N, Volk M, Kapovic M, Peterlin B. Genetic predisposition to idiopathic recurrent spontaneous abortion: contribution of genetic variations in IGF-2 and H19 imprinted genes. Am J Reprod Immunol 2008; 60: 111–117. [DOI] [PubMed]
  • 27.Solter D, Aronson J, Gilbert SF, McGrath J. Nuclear transfer in mouse embryos: activation of the embryonic genome. Cold Spring Harb Symp Quant Biol 1985; 50: 45–50. [DOI] [PubMed]
  • 28.Rodriguez S, Gaunt TR, O Dell SD, Chen XH, Gu D, Hawe E, et al. Haplotypic analyses of the IGF2-INS-TH gene cluster in relation to cardio vascular risk traits. Hum Mol Genet 2004; 13: 715–725. [DOI] [PubMed]
  • 29.Sandhu MS, Gibson JM, Heald AH, Dunger DB, Wareham NJ. Low circulating IGF-II concentrations predict weight gain and obesity in humans. Diabetes 2003; 52: 1403–1408. [DOI] [PubMed]
  • 30.Chen J, Fang Q, Chen B, Zhou Y, Luo Y. Study on the imprinting status of insulin-like growth factor II (IGF-II) gene in villus during 6-10 gestational weeks. Obstet Gynecol Int 2010; 2010: 965905–965908. [DOI] [PMC free article] [PubMed]
  • 31.Lighten AD, Hardy K, Winston RM, Moore GE. IGF2 is parentally imprinted in human preimplantation embryos. Nat Genet 1997; 15: 122–123. [DOI] [PubMed]
  • 32.Lighten AD, Hardy K, Winston RM, Moore GE. Expression of mRNA for the insulin-like growth factors and their receptors in human preimplantation embryos. Mol Reprod Dev 1997; 47: 134–139. [DOI] [PubMed]

Articles from International Journal of Reproductive Biomedicine are provided here courtesy of Shahid Sadoughi University of Medical Sciences and Health Services

RESOURCES